Palisade Bio's FY2023 Financial Results Overview

Wednesday, 27 March 2024, 12:13

Palisade Bio recently released its financial results for FY 2023, revealing a disappointing performance. The company reported a GAAP EPS of -$1.80, missing expectations by $0.85, along with revenue of $0.25 million. These results indicate challenges that Palisade Bio is facing in the current market conditions.
LivaRava Finance Meta Image
Palisade Bio's FY2023 Financial Results Overview

Palisade Bio Reports FY2023 Financial Performance

Palisade Bio recently released its financial results for FY 2023 with a GAAP EPS of -$1.80 and revenue of $0.25 million. The disappointing performance signals challenges ahead for the company.


This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.


Related posts


Newsletter

Get the most reliable and up-to-date financial news with our curated selections. Subscribe to our newsletter for convenient access and enhance your analytical work effortlessly.

Subscribe